Ivan V Litvinov Selected Research

Ivan V Litvinov Research Topics

Disease

25	Neoplasms (Cancer) 09/2023 - 12/2004
13	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2023 - 08/2013
8	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2024 - 08/2011
6	Prostatic Neoplasms (Prostate Cancer) 01/2014 - 07/2003
5	Inflammation (Inflammations) 01/2023 - 01/2014
5	Carcinogenesis 12/2022 - 08/2013
4	Skin Neoplasms (Skin Cancer) 11/2023 - 01/2022
4	Melanoma (Melanoma, Malignant) 09/2023 - 05/2021
4	Genomic Instability 01/2023 - 12/2018
4	Testicular Neoplasms (Testicular Cancer) 01/2023 - 07/2014
4	Skin Diseases (Skin Disease) 01/2022 - 01/2017
4	Dermatitis 01/2022 - 02/2010
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2023 - 03/2020
3	Atopic Dermatitis (Atopic Eczema) 01/2022 - 01/2021
3	Disease Progression 01/2018 - 02/2010
2	Localized Scleroderma (Morphea) 09/2023 - 11/2020
2	Alopecia (Baldness) 05/2023 - 01/2020
2	Systemic Scleroderma (Systemic Sclerosis) 12/2022 - 01/2022
2	Chromosomal Instability (Chromosome Stability) 06/2022 - 12/2018
2	Pruritus (Itching) 05/2021 - 09/2020
2	Eczema 05/2021 - 01/2017
2	Hypopigmentation (Hypomelanosis) 07/2020 - 01/2020
2	Mycosis Fungoides 01/2014 - 01/2014
1	Amenorrhea 05/2023
1	Diarrhea 05/2023
1	Dysgeusia (Parageusia) 05/2023
1	Vomiting 05/2023
1	Nausea 05/2023
1	Spasm (Spasms) 05/2023
1	Fatigue 05/2023
1	Weight Loss (Weight Reduction) 05/2023
1	Actinic Keratosis 03/2023
1	Brain Neoplasms (Brain Tumor) 01/2023
1	Cicatrix (Scar) 01/2023
1	Cutaneous Lupus Erythematosus 12/2022
1	Dermatomyositis (Dermatopolymyositis) 12/2022
1	Thrombosis (Thrombus) 11/2022
1	Psoriatic Arthritis 11/2022
1	Infections 11/2022
1	Lymphopenia (Lymphocytopenia) 03/2022
1	WHIM syndrome 03/2022
1	Bacterial Infections (Bacterial Infection) 03/2022
1	Neutropenia 03/2022

Drug/Important Bio-Agent (IBA)

7	CytokinesIBA 01/2023 - 01/2014
6	Androgen Receptors (Androgen Receptor)IBA 01/2014 - 07/2003
5	AntigensIBA 01/2023 - 07/2014
5	Proteins (Proteins, Gene)FDA Link 01/2023 - 10/2006
5	Biomarkers (Surrogate Marker)IBA 07/2022 - 01/2018
5	Interleukin-17 (Interleukin 17)IBA 01/2021 - 08/2013
4	RNA (Ribonucleic Acid)IBA 12/2022 - 01/2017
4	AndrogensIBA 01/2014 - 09/2006
3	HhAntag691IBA 05/2023 - 06/2020
3	Monoclonal AntibodiesIBA 01/2022 - 01/2021
3	MicroRNAs (MicroRNA)IBA 05/2020 - 01/2014
3	Messenger RNA (mRNA)IBA 06/2015 - 08/2013
2	Janus Kinase InhibitorsIBA 03/2024 - 01/2021
2	Immune Checkpoint InhibitorsIBA 09/2023 - 01/2021
2	CollagenIBA 12/2022 - 11/2020
2	LipidsIBA 11/2022 - 01/2022
2	Vitamin A (Retinol)FDA LinkGeneric 10/2022 - 03/2020
2	DNA (Deoxyribonucleic Acid)IBA 06/2022 - 12/2018
2	Immunoglobulin A (IgA)IBA 03/2022 - 05/2021
2	dupilumabIBA 01/2022 - 05/2021
2	InterleukinsIBA 05/2021 - 08/2013
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2020 - 07/2016
2	Formaldehyde (Formol)FDA Link 01/2017 - 01/2017
2	ParaffinIBA 01/2017 - 01/2017
2	Transcription Factors (Transcription Factor)IBA 03/2007 - 10/2006
1	Sunscreening Agents (Sunscreens)IBA 09/2023
1	sonidegibIBA 05/2023
1	Creatine Kinase (Creatine Phosphokinase)IBA 05/2023
1	Acitretin FDA Link 03/2023
1	Fluorouracil (Carac)FDA LinkGeneric 03/2023
1	Niacinamide (Nicotinamide)FDA LinkGeneric 03/2023
1	Small Interfering RNA (siRNA)IBA 01/2023
1	Etoposide (VP 16)FDA LinkGeneric 01/2023
1	Particulate MatterIBA 01/2023
1	Long Noncoding RNAIBA 12/2022
1	InterferonsIBA 12/2022
1	deucravacitinibIBA 11/2022
1	CreatinineIBA 11/2022
1	Antirheumatic Agents (DMARD)IBA 11/2022
1	Phosphotransferases (Kinase)IBA 11/2022
1	TYK2 Kinase (Tyrosine Kinase 2)IBA 11/2022
1	apremilastIBA 11/2022
1	RetinoidsIBA 10/2022
1	ChromatinIBA 06/2022
1	Immunoglobulin M (IgM)IBA 03/2022
1	Immunoglobulins (Immunoglobulin)IBA 03/2022
1	Immunoglobulin G (IgG)IBA 03/2022

Therapy/Procedure

17	Therapeutics 09/2023 - 07/2003
4	Immunotherapy 09/2023 - 12/2018
3	Biological Therapy 05/2021 - 03/2020
2	Precision Medicine 11/2023 - 12/2022
2	Radiotherapy 09/2023 - 01/2023
1	Drug Therapy (Chemotherapy) 09/2023
1	Electrocoagulation (Electrocautery) 06/2023
1	Chemoprevention 03/2023
1	Treatment Delay 11/2022
1	Off-Label Use 10/2022